AzTrials
AzTrials

LaborNCT07375836

The Effect of Chocolate Consumption During Labor on Second Stage Duration

A study testing 50 g of milk chocolate cocoa content 25-30% in people with Labor and Second Stage of Labor, run by Hillel Yaffe Medical Center.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Childbirth is an energy-intensive physiological process, requiring sustained effort comparable in intensity to moderate physical activity. Studies suggest that providing an available energy source during labor, such as dextrose infusion or natural carbohydrate-rich foods such as dates, may shorten the duration of… Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Labor, Second Stage of Labor, Pregnancy
What is being tested?
50 g of milk chocolate cocoa content 25-30%
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
No sites listed yet
Study dates
Feb 2026to Jan 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Gestational age ≥37 weeks
  • Single fetus in cephalic presentation
  • Spontaneous or induced labor in the active phase (dilation ≥ 5 cm).
  • Normal assessment of the mother and fetus upon admission to the delivery room (normal indices, normal monitoring and biophysical profile)
  • BMI 18-35 -

Who cannot join

  • Multiple pregnancies
  • Gestational age <37 weeks
  • Gestational or pre-gestational diabetes
  • Significant underlying diseases
  • Previous cesarean section/myomectomy
  • Known significant fetal malformation
  • Sensitivity to chocolate ingredients
  • Lack of documentation of necessary information -

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Libby O Madar, M.D contact

+972-4-7744602

NoaAl@hymc.gov.il

Rinat Gabbay-Benziv, M.D contact

+972-4-7744514

About this study

Childbirth is an energy-intensive physiological process, requiring sustained effort comparable in intensity to moderate physical activity. Studies suggest that providing an available energy source during labor, such as dextrose infusion or natural carbohydrate-rich foods such as dates, may shorten the duration of labor and improve cervical dilation without adversely affecting obstetric outcomes. The primary objective of the study is to examine whether giving chocolate during labor affects the duration of the second stage of labor, compared to a control group that will not receive a nutritional intervention. The study is a prospective, randomized, controlled trial that will be conducted in the delivery room of Hillel Yaffe Medical Center. Healthy pregnant women with a singleton pregnancy at ≥37 weeks gestational age, in spontaneous or induced labor, without diabetes (pre/gestational), will be recruited to participate. Participants in the intervention group will receive one serving of 50 grams of milk chocolate (cocoa content 25-30%, without filling or additives) at a cervical dilation of 6 cm or more (and not yet fully dilated). The mother will be asked to consume the serving gradually over 30 minutes. Milk chocolate was chosen because it is better tolerated compared to dark chocolate, has a more gentle profile of active ingredients (which can increase nausea and heartburn) and provides a source of available carbohydrates. The study will be conducted in accordance with the guidelines of the Ministry of Health's procedure for medical experiments on humans, and will be conducted after approval by the Institutional Helsinki Committee.

Being tested
50 g of milk chocolate cocoa content 25-30%
Keywords
Second stage of labor, Oral carbohydrate intake, Non-pharmacologic intervention, Maternal exhaustion, Pregnancy, Labor, Randomized controlled trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 50 g of milk chocolate cocoa content 25-30%Other

    Milk chocolate was chosen as it is better tolerated compared to dark chocolate, has a milder profile of active ingredients (which can increase nausea and heartburn) and provides a source of available carbohydrates.

    A dose of 50 grams was chosen that provides 25-30 grams of simple carbohydrates - sufficient for a significant increase in blood glucose but low enough to prevent a sudden sugar load or nausea.

    The intervention will be given at 6-9 cm dilation, towards the transition to the second phase - to allow the absorption of glucose and neurochemicals to be deafened at a time when the body needs increased energy and alertness. Giving it earlier may result in the effect of the chocolate wearing off before the second phase, and later - there will be no time for effective absorption.

Study groups in NCT07375836
Study groupRoleWhat they receive
50 g of milk chocolate cocoa content 25-30%Experimental. Participants in the intervention group will receive one serving of 50 grams of milk chocolate (cocoa content 25-30%, without filling or additives) at a cervical dilation of 6 cm or more. The mother will be asked to consume the serving gradually over 30 minutes.
Receives: Other: 50 g of milk chocolate cocoa content 25-30%
control group - no interventionNo interventionParticipants in the control group will receive routine care as is customary in the delivery room, without any proactive nutritional supplementation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of second stage of labor

    The duration of the second stage of labor, defined as the time in minutes from full cervical dulation (10cm) to delivery of the neonate.

    Measured: From full cervical dilation to delivery

Secondary outcomes (6)
  1. Mode of delivery

    Mode of delivery categorized as spontanous vaginal delivery, operative vaginal delivery (vacuum), or cesarean delivery

    Measured: At delivery

  2. Maternal nausea or vomiting during labor

    The occurrence of maternal nausea or vomiting during labor following the assigned intervention, as documented in the medical record

    Measured: From intervention administration untill discharge from labor room

  3. Neonatal Apgar score at 1 and 5 minutes

    The Apgar score is assessed at 1 and 5 minutes after delivery. The total score ranges from 0 to 10, with higher scores indicating better neonatal condition.

    Measured: 1 and 5 minutes after delivery

  4. Umbilical cord blood glucose level

    Umbilical cord blood glucose concentration measured from umbelical blood collected immediately after delivery (when a cord blood sample is obtained per routine practice

    Measured: at delivery

  5. Maternal heart rate

    Maternal heart rate measured in beats per minute as recorded by continous intrapartum maternal monitorind

    Measured: During the second stage of labor

  6. Umbelical cord blood PH

    Umbelical cord blood PH measures immediatley after delivery

    Measured: At delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2026
  2. Study startFeb 2026 (estimated)
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomized, parallel-group interventional study. Eligible participants will be randomized in a 1:1 ratio to receive either oral carbohydrate supplementation (chocolate) prior to second stage of labor, or standard intrapartum care. Outcomes will be compared between groups. The primary outcome is the duration of second stage of labor, with secondary maternal and neonatal outcomes assessed.
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07375836
Sponsor's protocol ID
0200-25-HYMC
Status last verified
Feb 2026
First submitted
21 Jan 2026
Last updated
4 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 50 g of milk chocolate cocoa content 25-30% in people with Labor and Second Stage of Labor, run by Hillel Yaffe Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Libby O Madar, M.D (+972-4-7744602, NoaAl@hymc.gov.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of second stage of labor (time frame: From full cervical dilation to delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in